Prescriber Perspectives and Experiences with Deprescribing Versus Continuing Bisphosphonates in Older Nursing Home Residents with Dementia.

Joshua D NiznikCathleen Colón-EmericCarolyn T ThorpeCasey J KelleyMeredith GilliamJennifer L LundLaura C Hanson

Published in: Journal of general internal medicine (2023)

Systems-level barriers to evaluating bone densitometry and treatment history in NHs may impede person-centered decision-making for fracture prevention. Further research is needed to evaluate the residual benefits of bisphosphonates in medically complex residents with limited mobility and dementia to inform recommendations for deprescribing versus continued use.

Keyphrases

mild cognitive impairment
decision making
cognitive impairment
patient safety
bone mineral density
clinical practice
middle aged
combination therapy
replacement therapy